Atlas Trials

Trial of the Efficacy of Intravenous Immunoglobulin for Treating Women With Unexplained Secondary Recurrent Miscarriage

Clinical trial NCT00722475 · COMPLETED

Trial details

NCT number
NCT00722475
Sponsor
Rigshospitalet, Denmark
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Secondary Recurrent Miscarriage
Start date
2008-08-01
Primary completion
2014-05-01
Enrollment
82

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.